Highlights
LSE: SAR       SAREUM HOLDINGS PLC ORD 0.025P
Last Price Today's Change   Day's Range   Trading Volume
1.375   -0.05 (3.51%)  1.315 - 1.545  6,088,824

Overview

 
Avg Volume (4 weeks):24,790,738
4 Weeks Range:1.081 - 2.291
4 Weeks Price Volatility (%):
24.30%
52 Weeks Range:0.03 - 3.093
52 Weeks Price Volatility (%):
43.91%
Average Price Target:-

Headlines



No recent Headlines for this stock.


Business Background

Sareum Holdings plc is engaged in the discovery and development of new therapeutic drugs by a combination of skills in biology, computational chemistry and medicinal chemistry. The Company's drug programs include Checkpoint Kinase 1 (CHK1), Aurora+FLT3 Kinase and Tyrosine Kinase 2- autoimmune diseases (TYK2), Aurora+FLT3 kinase and TYK2 kinase-cancer. Its Chk1 program is the advanced program and shows potency in disease models of lung and colon cancers in combination with chemotherapy; acute myeloid leukemia (AML) and B-cell lymphoma, and head and neck cancers in combination with radiotherapy. TYK2 kinase program focuses on developing a series of TYK2 inhibitors that can be dosed orally against various autoimmune and inflammatory disorders, including psoriasis and rheumatoid arthritis. Its Aurora+FLT3 Kinase program focuses on AML and other blood cancers. Its TYK2 kinase prevents T-cell acute lymphoblastic leukemia (T-ALL) cells from proliferating by causing programmed cell death.

  Be the first to like this.
 


APPS
I3 Messenger
Individual or Group chat with anyone on I3investor
 
 

2571  1975  830  2337 

ActiveGainersLosers
Top 10 Active Counters
 NameLastChange 
 ICON 0.012-0.001 
 WINZL 67.12-0.96 
 IPOST 390.75-4.60 
 SYME 0.393+0.033 
 UJO 0.157+0.006 
 VELA 0.073+0.002 
 LLOY 39.025-0.175 
 RMM 0.255+0.01 
 SD12 0.020.00 
 WIPAK 2,133.980.00